ATE547527T1 - Gruppe b streptococcus bvh-a2 und bvh-a3 antigene - Google Patents

Gruppe b streptococcus bvh-a2 und bvh-a3 antigene

Info

Publication number
ATE547527T1
ATE547527T1 AT01978039T AT01978039T ATE547527T1 AT E547527 T1 ATE547527 T1 AT E547527T1 AT 01978039 T AT01978039 T AT 01978039T AT 01978039 T AT01978039 T AT 01978039T AT E547527 T1 ATE547527 T1 AT E547527T1
Authority
AT
Austria
Prior art keywords
bvh
group
streptococcus
antigens
disclosed
Prior art date
Application number
AT01978039T
Other languages
English (en)
Inventor
Denis Martin
Stephane Rioux
Martine Boyer
Josee Hamel
Bernard Brodeur
Original Assignee
Id Biomedical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Id Biomedical Corp filed Critical Id Biomedical Corp
Application granted granted Critical
Publication of ATE547527T1 publication Critical patent/ATE547527T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT01978039T 2000-10-13 2001-10-15 Gruppe b streptococcus bvh-a2 und bvh-a3 antigene ATE547527T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23991900P 2000-10-13 2000-10-13
PCT/CA2001/001465 WO2002031156A2 (en) 2000-10-13 2001-10-15 Bvh-a2 and bvh-a3 antigens of group b streptococcus

Publications (1)

Publication Number Publication Date
ATE547527T1 true ATE547527T1 (de) 2012-03-15

Family

ID=22904311

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01978039T ATE547527T1 (de) 2000-10-13 2001-10-15 Gruppe b streptococcus bvh-a2 und bvh-a3 antigene

Country Status (8)

Country Link
US (2) US7335368B2 (de)
EP (1) EP1325133B1 (de)
JP (1) JP4102186B2 (de)
AT (1) ATE547527T1 (de)
AU (1) AU2002210301A1 (de)
CA (1) CA2424433A1 (de)
ES (1) ES2382893T3 (de)
WO (1) WO2002031156A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7595057B2 (en) * 2000-12-21 2009-09-29 Id Biomedical Corporation Streptococcus pyogenes antigens and corresponding DNA fragments
CN108103029B (zh) * 2017-12-12 2020-11-10 江苏省农业科学院 一株可裂解牛源无乳链球菌的噬菌体及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648241A (en) 1989-09-15 1997-07-15 The General Hospital Corporation Conjugate vaccine against group B streptococcus
IL107458A0 (en) 1992-11-02 1994-02-27 Gen Hospital Corp Conjugate vaccine against group b streptococcus
TR200002437T2 (tr) 1998-02-20 2000-11-21 Biochem Pharma Inc. B grubu streptococcus antijenleri.
GB9921125D0 (en) 1999-09-07 1999-11-10 Microbial Technics Limited Proteins

Also Published As

Publication number Publication date
WO2002031156A3 (en) 2003-02-27
US20080227706A1 (en) 2008-09-18
JP4102186B2 (ja) 2008-06-18
CA2424433A1 (en) 2002-04-18
US7335368B2 (en) 2008-02-26
US20040071730A1 (en) 2004-04-15
AU2002210301A1 (en) 2002-04-22
ES2382893T3 (es) 2012-06-14
JP2004510450A (ja) 2004-04-08
EP1325133A2 (de) 2003-07-09
EP1325133B1 (de) 2012-02-29
WO2002031156A2 (en) 2002-04-18

Similar Documents

Publication Publication Date Title
MXPA03000103A (es) Antigenos de streptococcus.
TR200102497T2 (tr) Yeni streptococcus antijenleri
NO20004161L (no) Gruppe B streptokoccus antigener
MXPA03009294A (es) Proteinas de superficie de streptococcus pyogenes.
ATE348887T1 (de) Streptococcus pneumoniae antigene und impfstoffe
ATE198051T1 (de) Pneumokokken-polysaccharid-rekombinante- pneumolysin-konjugate als impfstoffe für die immunisierung gegen pneumokokken-infektionen
ATE323721T1 (de) Cholin-bindendes protein, welches als gegen pneumokokken gerichtetes vakzin verwendet wird
FR21C1005I2 (fr) Antigenes de streptococcus pyogenes et fragments d'adn correspondants
WO2001081380A3 (en) Immunogenic pneumococcal protein and vaccine compositions thereof
MY141459A (en) Recombinant anti-idiotypic antibodies
WO2003068813A3 (en) Group b streptococcus antigen
NO20005952D0 (no) Neisseria Meningitidis antigene polypeptider, korresponderende polynukleotider og beskyttende antistoffer
AU2002210301A1 (en) Bvh-a2 and bvh-a3 antigens of group b streptococcus
WO2002028889A3 (en) Haemophilus influenzae antigens and corresponding dna fragments
DE60235223D1 (de) Streptococcus pyogenes polypeptide und entsprechende dna fragmente
DE60234772D1 (de) Gruppe-b streptococcus antigene und entsprechende dna-fragmente
ATE252642T1 (de) Attenuierte mutanten enteropathogenischer e. coli stämme (epec), verfahren deren produktion und verwendungen
BR0111886A (pt) Antìgeno para estreptococos
EP1950302A3 (de) Streptokokken-Antigene
ATE341613T1 (de) Fluordesoxyuridin-resistente streptococcus gordonii stämme
EP1219635A3 (de) Chlamydia pneumoniae Antigene
WO2004048575A3 (en) Streptococcus pneumoniae surface polypeptides
WO2002079475A3 (en) Streptococcus pyogenes antigens and corresponding dna fragments
WO2002088178A8 (en) Antigens of group b streptococcus and corresponding dna fragments